Lexeo Therapeutics
LXEO
LXEO
88 hedge funds and large institutions have $100M invested in Lexeo Therapeutics in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
88
Holders Change
-2
Holders Change %
-2.22%
% of All Funds
1.2%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
25
Reduced
23
Closed
18
Calls
$111K
Puts
$87K
Net Calls
+$24K
Net Calls Change
+$24K
Top Buyers
| 1 |
AAA
Affinity Asset Advisors
New York
|
+$5.14M |
| 2 |
Millennium Management
New York
|
+$3.23M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$2.24M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.21M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$893K |
Top Sellers
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$8.13M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.84M |
| 3 |
DCP
D1 Capital Partners
New York
|
-$4.25M |
| 4 |
ACM
Altium Capital Management
New York
|
-$2.66M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$1.02M |
